Astera Labs (NASDAQ:ALAB) Reaches New 12-Month High – Should You Buy?

Astera Labs, Inc. (NASDAQ:ALAB) shares hit a new 52-week high during mid-day trading on Tuesday . The stock traded as high as $316.50 and last traded at $299.10, with a volume of 1207917 shares traded. The stock had previously closed at $306.88.

Wall Street Analysts Forecast Growth

Several analysts have recently issued reports on ALAB shares. Jefferies Financial Group reissued a “buy” rating and set a $270.00 price target on shares of Astera Labs in a research report on Wednesday, May 6th. Citigroup cut shares of Astera Labs from a “buy” rating to a “market perform” rating in a research report on Tuesday. Royal Bank Of Canada increased their price target on shares of Astera Labs from $250.00 to $270.00 and gave the stock an “outperform” rating in a research report on Wednesday, May 6th. Barclays raised their target price on shares of Astera Labs from $165.00 to $200.00 and gave the company an “equal weight” rating in a report on Thursday, May 7th. Finally, JPMorgan Chase & Co. raised their target price on shares of Astera Labs from $205.00 to $280.00 and gave the company an “overweight” rating in a report on Wednesday, May 6th. Twelve investment analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $233.75.

Astera Labs Stock Up 6.0%

The company’s fifty day moving average is $182.05 and its two-hundred day moving average is $162.57. The stock has a market cap of $59.10 billion, a price-to-earnings ratio of 233.14, a PEG ratio of 4.22 and a beta of 3.35.

Astera Labs (NASDAQ:ALAB) last issued its earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, topping the consensus estimate of $0.54 by $0.07. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The business had revenue of $308.36 million for the quarter, compared to analyst estimates of $292.19 million. During the same quarter last year, the company earned $0.33 EPS. The business’s quarterly revenue was up 93.5% on a year-over-year basis. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. Sell-side analysts predict that Astera Labs, Inc. will post 1.84 EPS for the current fiscal year.

Insiders Place Their Bets

In other Astera Labs news, COO Sanjay Gajendra sold 400,000 shares of the firm’s stock in a transaction that occurred on Thursday, May 21st. The shares were sold at an average price of $290.30, for a total transaction of $116,120,000.00. Following the sale, the chief operating officer owned 5,064,213 shares of the company’s stock, valued at approximately $1,470,141,033.90. This trade represents a 7.32% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, General Counsel Philip Mazzara sold 796 shares of the firm’s stock in a transaction that occurred on Thursday, May 21st. The stock was sold at an average price of $291.03, for a total transaction of $231,659.88. Following the sale, the general counsel directly owned 103,343 shares in the company, valued at approximately $30,075,913.29. The trade was a 0.76% decrease in their position. The SEC filing for this sale provides additional information. Over the last quarter, insiders have sold 2,316,257 shares of company stock valued at $474,860,636. 12.50% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Astera Labs

A number of institutional investors have recently modified their holdings of the business. Vanguard Group Inc. increased its holdings in shares of Astera Labs by 0.6% in the 4th quarter. Vanguard Group Inc. now owns 13,827,506 shares of the company’s stock valued at $2,300,344,000 after acquiring an additional 84,365 shares during the period. Atreides Management LP increased its stake in Astera Labs by 108.9% in the 1st quarter. Atreides Management LP now owns 3,365,787 shares of the company’s stock valued at $368,890,000 after buying an additional 1,754,593 shares during the period. State Street Corp increased its stake in Astera Labs by 32.5% in the 4th quarter. State Street Corp now owns 3,099,809 shares of the company’s stock valued at $515,684,000 after buying an additional 760,358 shares during the period. Geode Capital Management LLC increased its stake in Astera Labs by 4.5% in the 4th quarter. Geode Capital Management LLC now owns 2,429,078 shares of the company’s stock valued at $403,598,000 after buying an additional 104,935 shares during the period. Finally, Fred Alger Management LLC increased its stake in Astera Labs by 25.5% in the 4th quarter. Fred Alger Management LLC now owns 1,934,688 shares of the company’s stock valued at $321,855,000 after buying an additional 393,250 shares during the period. 60.47% of the stock is owned by institutional investors and hedge funds.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.